S
EVH icon

SignatureFD’s Evolent Health EVH Stock Holding History

SignatureFD’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$135K Sell
24,928
-1,718
-6% -$6.59K ﹤0.01% 1289
2026
Q1 		$60.8K Buy
26,646
+15,744
+144% +$49.9K ﹤0.01% 1613
2025
Q4 		$43.6K Buy
10,902
+2,342
+27% +$13K ﹤0.01% 1731
2025
Q3 		$72.4K Sell
8,560
-2,609
-23% -$25.3K ﹤0.01% 1448
2025
Q2 		$126K Buy
11,169
+4,126
+59% +$37.9K ﹤0.01% 1134
2025
Q1 		$66.7K Buy
7,043
+5,636
+401% +$56.9K ﹤0.01% 1419
2024
Q4 		$15.8K Buy
1,407
+1,316
+1,446% +$23.1K ﹤0.01% 2175
2024
Q3 		$2.57K Sell
91
-187
-67% -$4.82K ﹤0.01% 2768
2024
Q2 		$5.32K Sell
278
-1,180
-81% -$30.1K ﹤0.01% 2491
2024
Q1 		$47.8K Buy
1,458
+13
+0.9% +$415 ﹤0.01% 1584
2023
Q4 		$47.7K Buy
1,445
+1,353
+1,471% +$38.3K ﹤0.01% 1494
2023
Q3 		$2.5K Buy
92
+58
+171% +$1.61K ﹤0.01% 2719
2023
Q2 		$1.03K Sell
34
-35
-51% -$1.13K ﹤0.01% 2965
2023
Q1 		$2.24K Sell
69
-460
-87% -$14.5K ﹤0.01% 2769
2022
Q4 		$14.9K Sell
529
-192
-27% -$5.5K ﹤0.01% 1947
2022
Q3 		$26K Buy
721
+41
+6% +$1.44K ﹤0.01% 1610
2022
Q2 		$21K Buy
680
+97
+17% +$2.83K ﹤0.01% 1739
2022
Q1 		$19K Sell
583
-1,144
-66% -$30K ﹤0.01% 1852
2021
Q4 		$48K Buy
1,727
+32
+2% +$918 ﹤0.01% 1358
2021
Q3 		$53K Hold
1,695
– – ﹤0.01% 1269
2021
Q2 		$36K Buy
1,695
+1,200
+242% +$24K ﹤0.01% 1431
2021
Q1 		$10K Buy
+495
New +$9.41K ﹤0.01% 1850

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

SignatureFD's EVH Position: Q2 2026 in Review

SignatureFD reduced its Evolent Health (EVH) stake by 6.4% in Q2 2026, selling an estimated $6.59K and leaving 24,928 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #1289.

SignatureFD first reported a position in EVH in Q1 2021 and has held it in 22 quarters since. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • SignatureFD held 24,928 shares of Evolent Health worth $135K as of Q2 2026.
  • SignatureFD sold 1,718 Evolent Health shares in Q2 2026, an estimated $6.59K.
  • Evolent Health made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #1289 holding.
  • SignatureFD first reported a position in Evolent Health in Q1 2021 and has held it in 22 quarters since.
  • 199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.